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Gene-targeted knockout technologies are invaluable tools for understanding the functions of genes in-
vivo. CRISPR/Cas9 system of RNA-guided genome editing is revolutionizing genetics research in a wide
spectrum of organisms. Here, we combined CRISPR with in vivo electroporation in the chicken embryo to
efﬁciently target the transcription factor PAX7 in tissues of the developing embryo. This approach
generated mosaic genetic mutations within a wild-type cellular background. This series of proof-of-
principle experiments indicate that in vivo CRISPR-mediated cell genome engineering is an effective
method to achieve gene loss-of-function in the tissues of the chicken embryo and it completes the
growing genetic toolbox to study the molecular mechanisms regulating development in this important
animal model.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Recent advances in the targeted modiﬁcation of complex eu-
karyotic genomes have unlocked a new era of genome engineer-
ing. From the pioneering work using zinc-ﬁnger nucleases (ZFNs
(Porteus and Carroll, 2005)) and transcription activator-like ef-
fector nucleases (TALEN (Miller et al., 2011)), to the recent devel-
opment of the highly accessible clustered, regularly interspaced
palindromic repeats (CRISPR)/Cas9 methodologies (Barrangou,
2014; Jinek et al., 2012; Pennisi, 2013; Wu et al., 2014), we now
possess an unprecedented ability to analyze developmental pro-
cesses using sophisticated designer genetic tools (Peng et al.,
2014).
While CRISPR-mediated gene editing is widely used to generate
loss-of-function in embryos and Primordial Germ Cells (PGCs)
(Doudna and Charpentier, 2014; Hsu et al., 2014), this technology
has also been used in mice to perform in vivo genome editing of
somatic cells (Sánchez-Rivera et al., 2014; Wang et al., 2014; Xue
et al., 2014; Yin et al., 2014). This approach creates genetic muta-
tions in a subset of cells within a wild-type background, a tech-
nology that was used extensively in the Drosophila ﬁeld to study
complex biological processes (Blair, 2003). The electroporation
technique, extensively used in the chicken embryo (Itasaki et al.,
1999; Nakamura and Funahashi, 2013; Scaal et al., 2004; Serralbo
et al., 2013; Voiculescu et al., 2008; Yokota et al., 2011), also results(C. Marcelle).
.in the mosaic expression of constructs, which, combined to loss-
of-function approaches, could provide similar advantages as in ﬂy.
However, gene inactivation in the chicken has been limited to
knockdown by RNA interference- and morpholino-based meth-
odologies (Das et al., 2006; Gros et al., 2009; Hou et al., 2011;
Norris and Streit, 2014; Rios et al., 2011; Serralbo and Marcelle,
2014; Voiculescu et al., 2008) that each have their own limitations,
including variability in the level of knockdown, off target effects,
and transient inhibition of transcripts.
Here we show that CRISPR-mediated gene targeting is an
amenable method of in vivo somatic cell genome editing in the
chicken. This technology will allow reﬁning the spatial and tem-
poral roles of genes during embryonic development. Additionally
this technology opens the door to further advances in the genetic
manipulations of avian species. Indeed, recent reports of geneti-
cally modiﬁed chickens using targeted gene knockout using the
TALEN technology in isolated chicken Primordial Germ Cells
(PGCs) (Park et al., 2014) suggests that the same strategy combined
with the easier CRISPR technique may soon be used at a large scale
to generate speciﬁc genome-edited avian lines.2. Results and discussion
2.1. Design of an inducible CRISPR-mediated gene-targeting system
We examined whether the CRISPR mediated gene-targeting
methodologies could be combined with the in ovo electroporation
technique for loss-of-function experiments in the chicken embryo.
As a proof-of-principle, we targeted the transcription factor PAX7,
Fig. 1. (A) Schematic representation of the genomic structure of Gallus gallus Pax7 locus, which is comprised of 10 exons spanning over 86 kilobase pairs of genomic DNA,
and encodes a protein of 524 amino acids. Guide RNAs were designed to target regions of exon 1 (1.1 and 1.7) or exon 2 (2.16 and 2.17). CRISPR-mediated cleavage and
deletion of the intervening genomic sequence should result in splicing defects represented as deletions 1–3 that lead to frame-shifts and premature stop codons and a
greatly shortened (only 24–33 amino-acid long) Pax7 protein. (B) Schematic of the Tol2 ﬂanked, inducible, CRISPR mediated gene-targeting vectors used in this paper.
N. Véron et al. / Developmental Biology 407 (2015) 68–74 69strongly expressed in the dorsal compartment of somites (the
dermomyotome) and in the dorsal part of the neural tube in early
amniote embryos. Since most if not all dermomyotome and dorsal
neural tube cells normally express this gene, we reasoned that an
effective loss-of-function of PAX7 would be unequivocally de-
tected (using a highly speciﬁc antibody against Pax7) as a lack of
PAX7 immunostaining in electroporated cells.
Our experimental setup necessitated that we have a robust
strategy that results in a conspicuous loss of the PAX7 protein. The
strategy of using two guide RNAs (gRNAs) to delete an intervening
segment by the introduction of two Double Stranded Breaks (DSB),
with repair via non-homologous end joining (NHEJ) has been
shown to be the most efﬁcient way to generate a deﬁned genomic
deletion (Canver et al., 2014; Ran et al., 2013; Zhou et al., 2014). We
therefore designed several pairs of gRNAs targeting exon 1 and
exon 2 of Pax7 (Fig. 1A). By using various combinations of these
gRNAs, we expected to generate deletions ranging from 28 bp to
over 2 kb in length. Such deletions should result in frame shift
mutations, premature stop codons and truncation of the majority
of the PAX7 protein (but for the N-terminal 24–33 amino acids,
depending on the gRNA pairs; Fig. 1A).
As in ovo electroporation results in a mosaic population of
transfected cells, we designed an experimental system that would
allow the identiﬁcation of CRISPR-targeted cells within the elec-
troporated tissue. Also we required a system that was amenable to
long-term analyses and be inducible, so that we could activate the
CRISPR-mediated deletion at different stages of embryogenesis.
We therefore designed an inducible CRISPR vector strategy, which
combines features from the Tet-On Advanced system (Clontech),Cas9 and gRNA vectors (Mali et al., 2013a) with the Tol2 transpo-
sable elements (Sato et al., 2007; Serralbo et al., 2013; Sieiro-Mosti
et al., 2014; Yokota et al., 2011).
The ﬁrst vector contains the Tet-On transactivator under the
control of the ubiquitous CAGGS promoter (CAGGS-rtTA). The
second vector contains a bi-directional tetracycline-response ele-
ment (TRE), which in the presence of doxycycline and rtTA, drives
the simultaneous expression of membranal EGFP and mammalian
codon-optimized, nuclear localized Cas9 (TRE-Cas9-GFP). The
third vector contains one Pax7-speciﬁc gRNA driven by the human
U6 promoter, as well as a second cassette containing the CAGGS
promoter driving RFP (U6-gRNA-RFP). Additionally, as all vectors
contain ﬂanking sequences from the Tol2 transposable element,
this allows their integration into the genome of electroporated
cells via the Tol2 transposase, thereby avoiding the gradual dilu-
tion of plasmids with cell division. The transposase, driven by a
CAGGS promoter, is provided on a fourth vector (CAGGS-Trans-
posase). This combination of 5 vectors (CAGGS-rtTA; TRE-Cas9-
GFP; 2X U6-gRNA-RFP; CAGGS-Transposase; illustrated in Fig. 1B)
permits the inducible expression of Cas9, and the identiﬁcation of
CRISPR Pax7-targeted cells as GFP- and RFP-positive cells.
2.2. CRISPR mediated deletion of PAX7
The Pax7-speciﬁc gRNA pairs along with the Tol2 ﬂanked, in-
ducible, CRISPR mediated gene-targeting vectors were electro-
porated into the dorsal neural tube or the newly formed somites of
E2.5 chicken embryos. We examined the loss of PAX7 in CRISPR
targeted cells 24 h post-electroporation, by immunoﬂuorescence
N. Véron et al. / Developmental Biology 407 (2015) 68–7470using the PAX7 monoclonal antibody. In addition, we performed
PCR-based mutation analysis to characterize the corresponding
deletion. At E3.5, PAX7 is highly expressed in the dorsal-most
portion of the neuroepithelium (Jostes et al., 1990; Marcelle et al.,
1995). Electroporation of the Pax7-gRNA pair (1.1 and 1.7) into the
neural tube along with the CRISPR mediated gene-targeting vec-
tors resulted in a signiﬁcant decrease or a loss in PAX7 staining in
Cas9/eGFP and gRNA/RFP positive cells, when compared to control
cells within the neural tube (Fig 2A–C). Quantitative analysis of the
PAX7 staining showed a robust decrease of PAX7 expression, since
only 20.95% of electroporated cells displayed normal levels of
PAX7 staining when compared to control electroporated cells,
suggesting that PAX7 knockdown has occurred in approximately
80% of cells (Fig 2G). As controls, we veriﬁed that this procedure
did not affect the expression of the closely related transcription
factor PAX3, or of the acetylated form of Tubulin. In addition, DAPI
staining conﬁrmed that it did not lead to any visible increase in
apoptosis (Supplementary Fig. 1).
PAX7 gene knockdown was also performed in the DML of so-
mites. Initially homogenously expressed in the dermomyotome,
Pax7 expression becomes progressively weaker in differentiating
somites in the DML as cells within this structure initiate their
myogenic program (Galli et al., 2008; Rios et al., 2011). Conse-
quently, we observed that approximately 65% of cells within the
DML of control electroporated somites expressed high levels of
Pax7. In comparison, only 14.5% of Cas9/eGFP and gRNA/RFP la-
beled cells within somites electroporated with the Pax7-gRNA pair
(1.1 and 1.7) expressed normal levels of Pax7 (Fig. 2D–F, H), again
demonstrating a signiﬁcant decrease in Pax7 staining.
Electroporation of other combinations of Pax7-gRNA pairs (1.7
with either 2.16 or 2.17) into the dorsal dermomyotome also re-
sulted in a drastic reduction of Pax7 staining (Fig 3A–I). Quanti-
tative measurement of the Pax7 staining demonstrated that lessNeural Tube DML
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Fig. 2. The neural tube or newly formed somites in E2.5 chicken embryos were electro
with doxycycline added at the time of the electroporation. (A–C) Transverse sections o
electroporation demonstrating the loss of Pax7 immunostaining speciﬁcally in the GFP an
of Pax7 in the (G) neural tube or (H) DML of cells electroporated with Pax7 targeted gRNA
bars: 25 μm.than 25% of the Cas9/eGFP and gRNA/RFP labeled cells have nor-
mal levels Pax7 staining (Fig 3J) when compared to control gRNA
electroporated somites where over 95% of cells have high levels of
Pax7 staining. The reduction of PAX7 expression we observed with
with all gRNA pairs suggested that the protocol and approach we
followed are very efﬁcient.
However, it was important to verify that the reduction or loss of
Pax7 expression was not artefactual but actually due to genome
editing in electroporated cells. To verify this, genomic DNA was
extracted from electroporated tissues and the Pax7 gene was
analyzed by PCR. We ﬁrst analyzed genomic DNA extracted from
cells electroporated with gRNAs from exon 1 (1.1 and 1.7, i.e.
leading to a 28 bp deletion). We did not observe the two (wild
type and mutated) DNA fragments after PCR ampliﬁcation of that
region, and T7 Endonuclease I assay was also unsuccessful to
identify the mutant genomic DNA. We believe this is due not only
to the small deletion, but more importantly to the relatively small
percentage of Cas9/GFP expressing cells within the dissected and
analyzed tissues. Rather than resorting to cumbersome cell-sort-
ing of electroporated cells to enrich for mutated cells (Wang et al.,
2014), we reasoned that a PCR reaction of a mixed population of
normal and mutant DNA would favor the detection of the latter as
deletions became larger. We therefore tested whether deletions of
about 2 kb would be easier to detect using the same strategy. In-
deed, the analysis of tissues collected from embryos electro-
porated with Pax7 gRNA pairs targeting exon 1 and exon 2 (1.7
with either 2.16 or 2.17, which resulted in a greater than 2 kb
genomic deletion), using a nested PCR approach, ampliﬁed DNA
fragments, readily visible as a smear of about the expected size
(800 bp and smaller) on a DNA gel (not shown). These were cloned
and sequenced. Analysis of sequences from individual clones
generated from these gRNA pairs conﬁrmed the deletion, however,
we observed important variations in the size of the indels in these0
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Fig. 3. The dorsal dermomyotome of newly formed somites in E2.5 chicken embryos were electroporated with the Tol2 ﬂanked, inducible, CRISPR mediated gene-targeting
vectors, with doxycycline added at the time of the electroporation, then analyzed 24 h post-electroporation. Confocal stacks showing the dorsal dermomyotome of somites
electroporated with (A–C) control gRNA versus gRNAs targeting various portions of exons 1 and 2 of Pax7 (D–F) 1.7 with 2.16 or (G–I) 1.7 with 2.17. Immunostaining for Pax7
within the GFP and RFP labeled cells showing the decrease or lack of Pax7 staining within the Pax7 gRNA targeted cells. (J) Graphs illustrating the percentage of ‘Pax7 hi’ cells
within the dermomyotome of control gRNAs versus Pax7 targeted gRNA electroporated somites. *** denotes P value of r0.001. Scale bars: 25 μm.
N. Véron et al. / Developmental Biology 407 (2015) 68–74 71clones (Fig. 4). Only 1 of 18 clones from Pax7 gRNA pair 1.7 and
2.16, and 1 of 14 clones from 1.7 and 2.17 contained the exact
predicted deletion, while the majority of cloned sequences con-
tained much larger deletions, with up to an additional 341 bp of
genomic sequence deleted in one instance, although on average
130 bp of sequence were deleted. This is surprising, as previous
reports of CRISPR mediated gene targeting in Xenopus, Zebraﬁsh
and Drosophila embryos suggest that the NHEJ repair mechanism
is very precise (Gratz et al., 2014; Guo et al., 2014; Hruscha et al.,
2013; Irion et al., 2014; Shen et al., 2014). However, our results
would suggest that the process of NHEJ can be error prone, maybe
in the speciﬁc context of electroporation. Importantly, regardless
of the range in size of the Pax7 genomic deletions, sequence
analysis of the CRISPR targeted clones conﬁrmed that all these
deletions resulted in aberrant mRNA splicing, changes to the open
reading frame and the presence of premature stop codons that
would result in truncated Pax7 protein, thereby explaining the loss
of Pax7 staining, detected by immunoﬂuorescence in these cells.3. Conclusion
This series of proof-of-principle experiments indicate that
in vivo CRISPR-mediated cell genome engineering is a highly ef-
fective method to achieve genetic mutations in a subset of cells of
the chicken embryo. Future improvements to the technology de-
scribed here will aim to reduce the number of co-electroporated
vectors: we show here that the co-electroporation of ﬁve vectors is
efﬁcient. However, this may become a limiting factor if an alter-
native strategy using modiﬁed Cas9 “nickase” is utilized. While the
main advantage of the Cas9 nickase is to greatly reduce the off-
target activity of the Cas9 endonuclease, it utilizes paired gRNAs to
create targeted double strand breaks in the genome (Mali et al.,
2013a; Ran et al., 2013). Large deletions described here would then
require four gRNAs (i.e. four U6-gRNA-RFP vectors). Multiplex
gRNA cloning kits that gather two or even four gRNAs at once in a
single vector (Systembio) would very effectively reduce this
number. Despite, this advancement in gene engineering now
Fig. 4. Strategy for CRISPR mediated deletion of exon 2 of Pax7, illustrating position of gRNAs targeting (A) exon 1 (1.7) and exon 2 (2.16) or (C) exon 1 (1.7) and exon 2 (2.17)
of Pax7. Gray box illustrates the expected deletion of (A) 2086 bp or (C) 2077 bp. Mutant alleles of Pax7 were identiﬁed using a nested PCR approach initially using primers
107 and 106, then primers 74 and 106 (black arrows). (B and D) Sequences of unique Pax7 mutant alleles compared to wildtype sequence. Underlined sequence indicates
gRNA target sequence with PAM in bold. Gray box illustrates the expected deletion. Red letters indicate inserted sequences. Dots indicate deleted bases. The total size of the
indel is shown in parentheses.
N. Véron et al. / Developmental Biology 407 (2015) 68–7472permits large scale loss-of-function analysis of candidate genes in
the chicken and the entry of this important animal model in the
genetic era.4. Materials and methods
4.1. CRISPR mediated gene-targeting vectors
The Tol2-pTRE-BI-eGFPcaax vector was derived from the bi-
directional doxycycline inducible pTRE-BI-eGFP vector (Clontech)
by the replacement of eGFP with a membrane-localized eGFP
(containing the CAAX prenylation sequence from H-Ras) along
with the addition of ﬂanking Tol2 integration sequences, into
which nuclear localized, human codon optimized Cas9 (Addgene
#41815, (Mali et al., 2013b)) was cloned to generate the TRE-Cas9-
GFP. We previously showed that this inducible plasmid system isTable 1
Primers used to clone Pax7 targets in hU6 gRNA plasmid.
Pax7 1.1 F TTTCTTGGCTTTATATATCTTGTGG
Pax7 1.1 R GACTAGCCTTATTTTAACTTGCTAT
Pax7 1.7 F TTTCTTGGCTTTATATATCTTGTGG
Pax7 1.7 R GACTAGCCTTATTTTAACTTGCTAT
Pax7 2.16 F TTTCTTGGCTTTATATATCTTGTGG
Pax7 2.16 R GACTAGCCTTATTTTAACTTGCTAT
Pax7 2.17 F TTTCTTGGCTTTATATATCTTGTGG
Pax7 2.17 R GACTAGCCTTATTTTAACTTGCTATsilent without doxycyclin (Rios et al., 2011). Tol2-CAGGS-rtTA has
been described previously (Serralbo et al., 2013). The hU6-gRNA
empty vector was obtained from Addgene (#41824, (Mali et al.,
2013b)). The hU6-gRNA scaffold cassette was cloned into Tol2-
CAGGS-RFP (Serralbo and Marcelle, 2014) to generate the U6-
gRNA-RFP. Pax7 target gRNAs were designed and selected as de-
scribed in Mali et al. (2013b), with further veriﬁcation of speciﬁcity
and off target effects using the CRISPR design tool (CRISPR.mit.edu,
(Hsu et al., 2014)). The veriﬁed gRNA target sequences (Table 1)
were cloned into the hU6 promoter gRNA scaffold primers in the
hU6 gRNA vector as described (Mali et al., 2013b). An empty gRNA
vector was used for control electroporations.
4.2. In ovo electroporation and imaging
Fertilized chicken eggs were incubated at 38 °C in a humidiﬁed
incubator. Embryos were staged according to days of incubationAAAGGACGAAACACCggtaccgcggatgatgcgcc
TTCTAGCTCTAAAACggcgcatcatccgcggtacc
AAAGGACGAAACACCgggcagaactacccgcgcac
TTCTAGCTCTAAAACgtgcgcgggtagttctgccc
AAAGGACGAAACACCgcccagggtgagtgcaatgt
TTCTAGCTCTAAAACacattgcactcaccctgggc
AAAGGACGAAACACCgccccacattgcactcaccc
TTCTAGCTCTAAAACgggtgagtgcaatgtggggc
Table 2
Primers used to detect Pax7 deleted genomic region.
74 Pax7 gDNA F1 ctccgccgccccccgctatgg
106 Pax7 gDNA R2 ccgtccttcagcagcctgtcccgg
107 Pax7 gDNA F2 ggctgggagacctccgaaagc
N. Véron et al. / Developmental Biology 407 (2015) 68–74 73and number of somites. The neural tube and somites were elec-
troporated as previously described (Gros et al., 2004; Rios et al.,
2011). The ﬁnal concentration for each plasmid in the electro-
poration mix was 1 mg/ml. Doxycycline (300 ml of 15 mg/ml) was
added at the time of electroporation. Embryos were analyzed
under UV examination 24 h after electroporation and correctly
electroporated embryos (i.e. high expression of the ﬂuorescent
reporters and no visible malformation due to electroporation)
were dissected and ﬁxed for 1 h in 4% formaldehyde.
Embryos were either analyzed by whole mount im-
munostaining or embedded in 15% sucrose/7.5% gelatin/PBS solu-
tion and sectioned into 20 mm slices using a cryostat (as described
in Serralbo and Marcelle (2014)). Immunohistochemistry on sec-
tions or whole mount embryos was performed with the following
antibodies: chicken polyclonal antibody against GFP (Abcam
#ab13970), rabbit polyclonal anti RFP (Abcam #ab62341), mouse
monoclonal Acetylated Tubulin (Sigma #T7451), mouse mono-
clonal anti Pax7 (Hybridoma Bank), mouse monoclonal anti Pax3
(Hybridoma Bank) detected with species-speciﬁc secondary anti-
bodies coupled to AlexaFluor-488,-555, or -647 (LifeTechnologies).
Whole-mount embryos and sections were imaged using a Leica
SP5 confocal microscope running LAS AF software (Leica
MicroSystems).
Image stacks were analyzed by using either (i) the Imaris
software package (Bitplane, version 7.5.2) or (ii) ImageJ software.
Using the “spot” module of the Imaris, the region of interest was
manually speciﬁed for each somite and an initial quality count for
gRNA-containing cells was performed. Selected cells were then
ﬁltered based on central intensity of Pax7 staining, and the in-
tensity peak value recorded as the percentage of positive
cells. Manual cell counting was performed using the cell counter
plugin (Kurt De Vos, University of Shefﬁeld) within ImageJ
(Schindelin et al., 2012) Statistical analyses were performed using
the GraphPad Prism software. Student's t-test was applied to po-
pulations to determine the P values indicated in the ﬁgures. In
each graph, columns correspond to the mean and standard de-
viation. *** denotes Po0.001.4.3. PCR analysis
Twenty-four hours after electroporation, tissue expressing both
GFP and RFP was dissected and pooled from three to ﬁve embryos
and genomic DNA extracted. The CRISPR targeted region was
ampliﬁed by a nested PCR approach with primers detailed in Ta-
ble 2, that preferentially ampliﬁed the CRISPR deleted region by
limiting the extension time of the PCR to 1 min. In the ﬁrst round
of PCR ampliﬁcation of the wildtype band (with forward and re-
verse primers 107 and 106) would result in an 3 kb band. A
second round of PCR was then performed (with forward and re-
verse primers 74 and 106) which preferentially ampliﬁed the
750 bp CRISPR deleted band over the 2.9 kb wildtype band.
The PCR products were gel puriﬁed and cloned into the pGEMt-
Easy vector (Promega) by TA cloning. Ten single colonies were
randomly picked for DNA sequencing analysis to detect the in-
sertion or deletion of bases. Sequences were aligned and analyzed
using SnapGene (GSL Biotech).Author contributions
CH and CM planned the experiments and wrote the manu-
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